Promethera Biosciences Competitors and Similar CompaniesClear all
Intercept Pharmaceuticals's competitors and similar companies include Gilead Sciences.
 Intercept Pharmaceuticals Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases. |  Gilead Sciences Gilead Sciences is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of medicines. | |
Founding Date | Founding Date 2002 | Founding Date 1987 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations New York, US HQ Wien, AT Mississauga, CA Kongens Lyngby, DK Paris, FR München, DE Dublin, IE see more | Locations Foster City, US HQ Buenos Aires, AR Melbourne, AU Wien, AT Machelen, BE São Paulo, BR Edmonton, CA see more |
Employees | Employees 58321% increase | Employees 18,0006% increase |
Valuation ($) | Valuation ($) 794.7 m | Valuation ($) 110.5 b |
Financial | ||
Revenue (est.) | Revenue (est.) $285.7m (FY, 2022) | Revenue (est.) $29.4b (FY, 2025) |
Cost of goods | Cost of goods $984k (FY, 2022) | Cost of goods $6.2b (FY, 2025) |
Gross profit | Gross profit $284.7m (FY, 2022) | Gross profit $23.2b (FY, 2025) |
Net income | Net income $221.8m (FY, 2022) | Net income $8.5b (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Gilead Sciences
HQ
Foster City, US
Employees
18,000↑ 6% increase
Gilead Sciences is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of medicines.
View company